A Glimpse Into The Expert Outlook On Sarepta Therapeutics Through 9 Analysts
A Glimpse Into The Expert Outlook On Sarepta Therapeutics Through 9 Analysts
通過9位分析師的專業展望，瀏覽sarepta therapeutics的市場前景。
9 analysts have expressed a variety of opinions on Sarepta Therapeutics (NASDAQ:SRPT) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在過去的一個季度中，9位分析師就Sarepta Therapeutics（NASDAQ:SRPT）發表了不同的意見，提供了從看好到看淡的多樣化的觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他們最近的評級，展示了過去30天內的情緒演變並與之前的幾個月進行了比較。
In the assessment of 12-month price targets, analysts unveil insights for Sarepta Therapeutics, presenting an average target of $162.56, a high estimate of $180.00, and a low estimate of $128.00. This current average reflects an increase of 2.61% from the previous average price target of $158.43.
在評估12個月的價格目標時，分析師揭示了針對Sarepta Therapeutics的見解，提供了平均目標爲162.56美元，高估爲180.00美元，低估爲128.00美元的多樣化預測。當前平均值比之前的158.43美元的平均目標價格上漲了2.61%。
Decoding Analyst Ratings: A Detailed Look
分析師評級解讀：詳細解析
A comprehensive...
對S...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。